AML 8278 contained immature CD34-positive and more mature CD34-negative cell populations, whereas AML 16072 consisted of a mix of immature and mature cell populations with low and high CD14 expressions, respectively. This evidence concerns the gene CD14 and acute myeloid leukemia.